Clinical Trials

NCT05741164 | RECRUITING | PHASE2
37 participants

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2024-09-01
Completion:
2028-06-30
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Refractory Triple-Negative Breast Carcinoma
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT05516537 | COMPLETED | NA
121 participants
NCT05486559 | COMPLETED | NA
225 participants

The ECMO-Free Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2022-09-07
Completion:
2026-04-18
Conditions
  • Extracorporeal Membrane Oxygenation Complication
Interventions
  • OTHER
No Results Yet
NCT05419479 | SUSPENDED | PHASE1/PHASE2
46 participants

Switch Maintenance in Pancreatic

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2022-11-30
Completion:
2026-05-17
Conditions
  • Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • Squamous Cell Carcinoma of Pancreas
  • Adenosquamous Carcinoma of the Pancreas
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page